MPLT MapLight Therapeutics, Inc.: institutional ownership and insider trading
109 funds reported holding $958M of MapLight Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $58.6M, with 36 new positions and 10 funds selling out; over the last 12 months insiders bought $175M and sold $30.2M on the open market.
MPLT revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$60.2M, EPS -1.32
- Quarter ended Mar 31, 2026: revenue n/a, net income −$60.7M, EPS -1.34
- Quarter ended Dec 31, 2025: revenue n/a, net income −$79.5M, EPS 87.06
- Quarter ended Sep 30, 2025: revenue n/a, net income −$29.4M, EPS -37.18
Famous investors holding MPLT
- Izzy Englander (Millennium Management): $4.62M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.53M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $322K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $249K, 0.0% of the portfolio
Largest institutional holders of MPLT
- Novo Holdings A/S — $132M
- FCPM III SERVICES B.V. — $116M
- T. Rowe Price Investment Management, Inc. — $99.7M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $69.8M
- PRICE T ROWE ASSOCIATES INC /MD/ — $51.0M
- BlackRock, Inc. (BLK) — $36.7M
- Nan Fung Group Holdings Ltd — $34.8M
- 5AM Venture Management, LLC — $34.0M
- Sanofi (SNY, SNYNF) — $32.7M
- STATE STREET CORP (STT, STT-PG) — $30.5M
Recent MPLT insider trades
- Oct 15, 2026: Kroeger Christopher A. sold 73,691 shares ($595K)
- Oct 15, 2026: Gillis Jonathan sold 10,167 shares ($82.1K)
- Oct 15, 2026: Lillie James Woodruff sold 11,513 shares ($93.0K)
- Oct 15, 2026: Hanson Kristopher sold 9,020 shares ($72.9K)
5%+ owners
- Catalyst4, Inc.: 49.9% (Schedule 13D/A, filed Aug 18, 2026)
- T. Rowe Price Investment Management, Inc.: 7.4% (Schedule 13G/A, filed May 15, 2026)
- Nan Fung Group Holdings Limited: 5.5% (Schedule 13G, filed Aug 20, 2026)
Who owns the most MPLT stock?
The largest institutional holders of MapLight Therapeutics, Inc. in the latest 13F filings are Novo Holdings A/S ($132M), FCPM III SERVICES B.V. ($116M), T. Rowe Price Investment Management, Inc. ($99.7M).
Are insiders buying or selling MPLT?
Over the last 12 months insiders bought $175M and sold $30.2M of MapLight Therapeutics, Inc. stock on the open market (SEC Form 4).
Which famous investors own MPLT?
Izzy Englander, Ken Griffin, Two Sigma, Renaissance Technologies.
Which ETFs hold MPLT?
5 ETFs and mutual funds hold it among their top 100 positions, including FBTAX, LZCOX, TMED, ASD.